Team:ITESM-Guadalajara/Product
From 2014.igem.org
(Difference between revisions)
(26 intermediate revisions not shown) | |||
Line 229: | Line 229: | ||
.faceBot{ | .faceBot{ | ||
- | background: | + | background: #202020; |
} | } | ||
Line 369: | Line 369: | ||
<a href="https://2014.igem.org/Main_Page"> | <a href="https://2014.igem.org/Main_Page"> | ||
<span>iGEM 2014</span> | <span>iGEM 2014</span> | ||
+ | <span class="green-effect"></span> | ||
+ | </a> | ||
+ | </li><li class="menu-item"> | ||
+ | <a href="https://2014.igem.org/Team:ITESM-Guadalajara/Notebook"> | ||
+ | <span>Notebook</span> | ||
<span class="green-effect"></span> | <span class="green-effect"></span> | ||
</a> | </a> | ||
Line 385: | Line 390: | ||
<li class="left_menu_item_selected"><a href="https://2014.igem.org/Team:ITESM-Guadalajara/Product">Our Product</a></li> | <li class="left_menu_item_selected"><a href="https://2014.igem.org/Team:ITESM-Guadalajara/Product">Our Product</a></li> | ||
<li class="left_menu_item"><a href="https://2014.igem.org/Team:ITESM-Guadalajara/Technology">Our Technology</a></li> | <li class="left_menu_item"><a href="https://2014.igem.org/Team:ITESM-Guadalajara/Technology">Our Technology</a></li> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
</ul> | </ul> | ||
</div> | </div> | ||
Line 402: | Line 399: | ||
Biophrame Technologies is committed to be one of the most innovative high biotech companies in Mexico, providing quality and affordable raw materials that can help the development of the health industry in Mexico.</p> | Biophrame Technologies is committed to be one of the most innovative high biotech companies in Mexico, providing quality and affordable raw materials that can help the development of the health industry in Mexico.</p> | ||
- | <p align="justify">Initially we are going to focus on producing Chitosan with pharmaceutical grade to be used as raw material in health industry; however, thanks to the enormous uses Chitosan has in many industries, our production process provides significant opportunities to expand our market beyond, through the development of new products where Chitosan provides added value.</p> | + | <p align="justify">Initially we are going to focus on producing Chitosan (see image below) with pharmaceutical grade to be used as raw material in health industry; however, thanks to the enormous uses Chitosan has in many industries, our production process provides significant opportunities to expand our market beyond, through the development of new products where Chitosan provides added value.</p> |
+ | <img src="https://static.igem.org/mediawiki/2014/f/f0/BIOPHRAMEpowder.jpg" width="650" height="340"> | ||
<hr> | <hr> | ||
<h4>Chitosan definition, applications and properties</h4> | <h4>Chitosan definition, applications and properties</h4> | ||
<p align="justify">Chitosan is a biopolymer derived from chitin (a naturally occurring polysaccharide widely distributed in nature, especially exoskeletons of some animals such as shrimps and insects) with a unique chemical structure as a linear polycation with a high charge density, hydrogen bonding, reactive hydroxyl and amino groups that help Chitosan display excellent biocompatibility, biodegradability, non-toxicity, physical stability, hemostatic activity and processability properties, which has attracted the attention of scientists and industries for its utilization in many applications of technical interest (Raafat & Sahl, 2009).</p> | <p align="justify">Chitosan is a biopolymer derived from chitin (a naturally occurring polysaccharide widely distributed in nature, especially exoskeletons of some animals such as shrimps and insects) with a unique chemical structure as a linear polycation with a high charge density, hydrogen bonding, reactive hydroxyl and amino groups that help Chitosan display excellent biocompatibility, biodegradability, non-toxicity, physical stability, hemostatic activity and processability properties, which has attracted the attention of scientists and industries for its utilization in many applications of technical interest (Raafat & Sahl, 2009).</p> | ||
+ | |||
+ | <img src="https://static.igem.org/mediawiki/2014/d/db/BIOPHRAMEapplications.jpg" width="650" height="370"> | ||
<p align="justify">Chemically, Chitosan is a copolymer composed by β-(1→4)-2-acetamido-D-glucose and β-(1→4)-2-amino-D-glucose units (see figure below), where the relative amount of GlcNAc and D‐glucosamine (GlcN) monosacharides may vary giving different degrees of deacetylation (75–95%), molecular weights (MWs) (50–2000 kDa), viscosities, pKa values, etc (Raafat & Sahl, 2009).</p> | <p align="justify">Chemically, Chitosan is a copolymer composed by β-(1→4)-2-acetamido-D-glucose and β-(1→4)-2-amino-D-glucose units (see figure below), where the relative amount of GlcNAc and D‐glucosamine (GlcN) monosacharides may vary giving different degrees of deacetylation (75–95%), molecular weights (MWs) (50–2000 kDa), viscosities, pKa values, etc (Raafat & Sahl, 2009).</p> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/4/4b/BIOPHRAMEchitinchitosan.jpg" width="650" height="320"> | ||
- | |||
<hr/> | <hr/> | ||
<h4>Health Applications</h4> | <h4>Health Applications</h4> | ||
Line 542: | Line 542: | ||
<li> Food industry (as dietary supplements)</li> | <li> Food industry (as dietary supplements)</li> | ||
</p> | </p> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/0/02/BIOPHRAMEbiokmedium.jpg" width="370" height="400"> | ||
<p align="justify">Also, as we discovered throw our marketing research with some mexican pharmaceutical industries, some of which are interested in our product, (see human practice and marketing sections), there is a need of bigger presentations; that is why we also offer a 10 kg presentation.</p> | <p align="justify">Also, as we discovered throw our marketing research with some mexican pharmaceutical industries, some of which are interested in our product, (see human practice and marketing sections), there is a need of bigger presentations; that is why we also offer a 10 kg presentation.</p> | ||
- | <hr/> | + | <hr/></ul> |
<h4>Future Generation Products</h4> | <h4>Future Generation Products</h4> | ||
<p align="justify">In the future, Biophrame Technologies expect to amplify its production plant for the generation of a new product: High Purity Chitosan (Degree of deacetylation: 90-99 %). This product will be sold in 1 g presentation with standard chemical and physical properties to be used in: | <p align="justify">In the future, Biophrame Technologies expect to amplify its production plant for the generation of a new product: High Purity Chitosan (Degree of deacetylation: 90-99 %). This product will be sold in 1 g presentation with standard chemical and physical properties to be used in: | ||
Line 563: | Line 564: | ||
<li>Therapeutic agent delivery systems, among others</li> | <li>Therapeutic agent delivery systems, among others</li> | ||
</li></ul></p> | </li></ul></p> | ||
+ | </ul> | ||
+ | <img src="https://static.igem.org/mediawiki/2014/8/86/BIOPHRAMEbiokhigh.jpg" width="450" height="320"> | ||
<p align="justify">As in the case of medium-low purity chitosan, some pharmaceutical companies and research centers in Mexico are interested in our product, however some of them buy 1g presentation for research purposes while others 10kg presentation (mainly for pharmaceutic preparations); therefore, we will offer both of them to satisfy the customer desires.</p> | <p align="justify">As in the case of medium-low purity chitosan, some pharmaceutical companies and research centers in Mexico are interested in our product, however some of them buy 1g presentation for research purposes while others 10kg presentation (mainly for pharmaceutic preparations); therefore, we will offer both of them to satisfy the customer desires.</p> | ||
- | < | + | <hr/> |
</div> | </div> | ||
Latest revision as of 05:30, 11 January 2015